[Federal Register Volume 61, Number 196 (Tuesday, October 8, 1996)]
[Notices]
[Page 52802]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-25861]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given to the meetings 
of the National Cancer Institute Special Emphasis Panel (SEP):

    Name of SEP: Development of Dosage Forms & Delivery Systems for 
Antitumor and Anti-AIDS Agents.
    Date: October 4, 1996.
    Time: October 4--8:30 am.
    Place: Executive Plaza North, Conference Room G, 6130 Executive 
Boulevard, Rockville, MD 20852.
    Contact Person: Dr. Courtney Michael Kerwin, Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 601, 6130 Executive Boulevard MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/496-7421.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.

    Name of SEP: Modulation of Apoptosis to Improve Cancer Therapy.
    Date: October 6-7, 1996.
    Time: October 6--8 pm, October 7--8 am.
    Place: Holiday Inn--Georgetown, 2101 Wisconsin Avenue, NW, 
Washington, DC 20007.
    Contact Person: Dr. David Irwin, Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 635E, 6130 Executive Boulevard MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/406-0371.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.

    Name of SEP: Evaluation of Chemopreventive Agents by In Vitro 
Techniques.
    Date: October 7, 1996.
    Time: October 7--2 pm.
    Place: Executive Plaza North, 6130 Executive Boulevard, 
Rockville, MD 20852.
    Contact Person: Dr. Lalita D. Palekar, Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 601, 6130 Executive Boulevard MSC 7405, Bethesda, MD 
20892-7405, Telephone: 301/496-7575.
    Purpose/Agenda: This meeting will be devoted to the review, 
discussion, and evaluation of a grant application.

    The meetings will be closed in accordance with the provisions 
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    This notice is being submitted less than 15 days prior to the 
above meetings due to the urgent need to meet timing limitations 
imposed by the review and funding cycle.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: October 3, 1996.
Paula N. Hayes,
Acting Management Officer, NIH.
[FR Doc. 96-25861 Filed 10-3-96; 4:51 pm]
BILLING CODE 4140-01-M